JPRN-UMIN000004972已完成未知
Effect of branched-chain amino acids (BCAA) supplementation for patients with non alcoholic fatty liver disease (NAFLD) - Effect of BCAA for NAFLD
Kagoshima University hospital, Center for Gastroenterology, Gastroenterological Medicine0 个研究点目标入组 15 人开始时间: 2011年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patient with viral hepatitis. 2. Alcohol consumer [alcohol intake (ethanol)>=20g/day]. 3. Patient with Hepatocellular carcinoma. 4. Diabetes patients treated with insulin or oral antihyperglycemic drug or uncontrolled patients (HbA1c>=8). 5. Patients who have already been taking BCAA. 6. Subjects who have already been taking amino-acid supplement. 7. Patients with amino-acid metabolism abnormality. 8. Subjects who are judged for non-approved by principal investigator.
研究者
相似试验
尚未招募
不适用
The role of branched-chain amino acids (BCAAs) in the stimulation of skeletal muscle protein synthesis and glucose uptake in healthy, young volunteersinsulin resistanceNL-OMON53406Wageningen Universiteit28
Enrolling By Invitation
4 期
Effect of branched-chain amino acid supplements on frailty liver index in patients with liver cirrhosisBranched-chain amino acid supplements will improved frailty index in patients with all stage of cirrhosis.Branched-chain amino acid supplement , liver frailty indexTCTR20210928001Thammasat University52
尚未招募
2 期
The effect of branched-chain amino acid granules to innate immunity in decompensated cirrhosis, A randomized controlled trialLiver CirrhosisDecompensated cirrhosis,Child-Pugh B,C with documented ascitesand MELD score < 20Amino Acids,Branched-ChainImmunity,InnateTCTR20190830005Faculty of Medicine, Prince of Songkla University72
已完成
不适用
Impact of Branch Chain Amino Acid (Protein) on Liver Cirrhosis PatientsCTRI/2020/04/024762ims University Rajasthan Jaipur India138
招募中
不适用
The beneficial effect of branched-chain amino acids with combined peginterferon alpha-2b plus ribavirin for chronic hepatitis C patientsChronic hepatitis type CJPRN-UMIN000004252Department of Gastroenterology, Yamaguchi Univercity Graduate School of Medicine100